FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1838-1839 June 15, 2000 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Exposure to diethylstilbestrol (DES) in utero is related to an increased risk of clear-cell adenocarcinoma of the vagina and cervix at a young age.¹ However, the long-term risk of cancer in the daughters of women given DES during pregnancy (DES daughters) is still unknown. To date, only one study has examined the risk of cancer in adult DES daughters, and no increased risks were found in that study, except for an increased risk of clear-cell adenocarcinoma of the vagina and cervix.²

We analyzed data from a questionnaire mailed to 13,350 DES daughters registered at the Netherlands DES . . . [Full Text of this Article]

References

This article has been cited by other articles:

• PROKAI-TATRAI, K., PROKAI, L. (2005). Impact of Metabolism on the Safety of Estrogen Therapy. Ann. N. Y. Acad. Sci. 1052: 243-257 [Abstract] [Full Text]  
• Bhat, H. K., Calaf, G., Hei, T. K., Loya, T., Vadgama, J. V. (2003). Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl. Acad. Sci. USA 100: 3913-3918 [Abstract] [Full Text]